FDA approves Alexion's Soliris for another rare disease; Sun Pharma debuts companion mobile app for acne drug; Hurricane halts manufacturing in Puerto Rico
Rosa talks about the wearable technology company's health and fitness plans and other areas of expansion.
Alexion to cut 600 jobs; Sage Therapeutics' experimental seizure drug fails to meet expectations; Apple is interested in medical and health activity
Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit
Drug ads on mobile are not providing enough risk info; rare-disease drugmakers are concerned about healthcare bill; volume of opioid prescriptions drops
One executive referred to AI as a "black box" and as the "Tower of Babel."
David Van Sickle is CEO and co-founder of Propeller Health.
Dr. Ashish Atreja is the director of the Sinai AppLab at the Icahn School of Medicine.
Sam Frons is founder of Addicaid.
Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem
Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.
We at MM&M found out just how much pharma marketers love a list. Here, read through the year's most-read technology stories.
The connection to Pristiq is not overt in the app's user interface, though Moodivator is featured on Pristiq's website.
Lilly to offer discounts for insulin products; Trump reportedly considering Scott Gottlieb to lead FDA; three execs depart Valeant
Adherence is one of the biggest challenges physicians face in diabetes management.
The search-engine giant says that one in 20 online searches are related to healthcare, and more users are using mobile to consume media.
Jawbone data shows that people mentioning Pokémon Go in their comments have been walking 62.5% more than usual.
U.S. companies accounted for nearly a quarter of the startups funded to celebrate Publicis' 90th anniversary.
In partnership with inVentiv Health, MM&M found a millennial doctor to ask about her frustrations with the existing pharma marketing model to her willingness to text patients.
Pfizer brand teams competed in a shark-tank style challenge, with the winning teams receiving funding for their ideas.
It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.
While they may not be at the top of a long list of priorities, the sheer size (all 75.3 million of them!) of millennials makes them too important to overlook.
Online doctors prescribe drugs without adequate warnings; House lawmakers to discuss Part B proposal; obesity drugs struggle for market share
At the MM&M Transforming Healthcare conference, Iyengar told attendees how to take into account a consumer's behavior and emotion when marketing medical products.
CeyHello, a newly launched social networking mobile app, tackles medication adherence by connecting patients, caregivers and family members.
Monique Levy, who's spent more than a decade helping drugmakers understand technology shifts, has joined PatientsLikeMe, the online discussion platform for people with chronic illness.
Facebook has found that 43% of people who watch the first three seconds of a video will stay for 10 seconds. To create engagement, agencies need to rethink the creative approach.
Welcome to the mobile era for clinical trials, in which phone and tablet technology promise to upend a costly and unwieldy process.
Physicians like mobile and they prefer the iPhone to Android devices — and that knowledge is changing the way drugmakers promote their products online.
An initial list of consumer health tech deemed essential by MIT and Harvard doctors is short on pharma-backed apps or services.